Colgate-Palmolive (NYSE:CL) Shares Sold by 44 Wealth Management LLC

44 Wealth Management LLC cut its holdings in Colgate-Palmolive (NYSE:CL) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,238 shares of the company’s stock after selling 1,036 shares during the period. 44 Wealth Management LLC’s holdings in Colgate-Palmolive were worth $1,749,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Swedbank AB increased its position in Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares during the period. Sequoia Financial Advisors LLC grew its stake in shares of Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares during the period. Private Advisor Group LLC lifted its position in shares of Colgate-Palmolive by 5.4% during the 3rd quarter. Private Advisor Group LLC now owns 68,952 shares of the company’s stock valued at $7,158,000 after acquiring an additional 3,543 shares during the period. International Assets Investment Management LLC boosted its position in Colgate-Palmolive by 13,776.8% during the third quarter. International Assets Investment Management LLC now owns 435,871 shares of the company’s stock worth $45,248,000 after purchasing an additional 432,730 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. increased its holdings in Colgate-Palmolive by 4.2% during the 3rd quarter. Hennion & Walsh Asset Management Inc. now owns 20,975 shares of the company’s stock valued at $2,177,000 after acquiring an additional 851 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.9 %

CL stock opened at $89.56 on Friday. The business has a 50 day moving average of $88.94 and a 200 day moving average of $95.91. The firm has a market cap of $72.68 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a twelve month low of $84.45 and a twelve month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business posted $0.87 EPS. On average, research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Morgan Stanley decreased their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.